The harm done by ultra-processed foods — those that have so many additives and have undergone so much processing they're far ...

Laboratories face a series of upcoming deadlines to comply with stricter FDA oversight of in-house tests. Here are five ...

In a complete response letter, the FDA cited minor deficiencies related to drug substance, product, manufacturing and ...

Recent health news includes FDA's approval of Astellas' gastric cancer therapy, the resignation of CVS Health CEO Karen Lynch ...

Novartis, however, said that the federal Food, Drug, and Cosmetic Act prevented MSN from "reverting" to an older label that ...

The states of Missouri, Kansas, and Idaho argue in the new lawsuit that “women should have the in-person care of a doctor ...

California is banning them in schools. The FDA says they’re fine. But synthetic dyes added to food to make them more colorful have a long, troubled history.

Basel, October 29, 2024 – Novartis announced today that Scemblix ® (asciminib) was granted accelerated approval by the US Food and Drug Administration (FDA) for adult patients with newly diagnosed ...

PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has issued a ...

This regular publication by DLA Piper lawyers focuses on helping clients navigate the ever-changing business, legal, and regulatory landscape.

ORLYNVAH™ is the first oral penem approved for use in the U.S. and the second FDA-approved treatment for uUTIs in the past two decades--Company ...